Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial

Catherine A. Shu(Columbia University Irving Medical Center), Justin F. Gainor(Massachusetts General Hospital), Mark M. Awad(Dana-Farber Cancer Institute), Codruța Chiuzan(Columbia University Irving Medical Center), Claud Grigg(Levine Cancer Institute), Aliyah Pabani, Robert F. Garofano(Columbia University Irving Medical Center), Mark Stoopler(Columbia University Irving Medical Center), Simon K. Cheng(Columbia University Irving Medical Center), Abby White(Dana-Farber Brigham Cancer Center), Michael Lanuti(Massachusetts General Hospital), F. D’Ovidio(Columbia University Irving Medical Center), Matthew Bacchetta(Vanderbilt University Medical Center), Joshua Sonett(Columbia University Irving Medical Center), Anjali Saqi(Columbia University Irving Medical Center), Naiyer A. Rizvi(Columbia University Irving Medical Center)
The Lancet Oncology
May 7, 2020
Cited by 636

Abstract


Related Papers

No related papers found

Powered by citation graph analysis